Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Adipose markers of metabolic outcome after weight loss

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • بيانات النشر:
      Inst för medicin, Huddinge / Dept of Medicine, Huddinge
    • الموضوع:
      2019
    • Collection:
      Karolinska Institutet: Publications
    • نبذة مختصرة :
      Adipose tissue is closely linked to metabolic disturbances in obesity. Bariatric surgery such as roux-en-Y gastric bypass (RYGB) remains the most effective treatment of obesity and obesity-related disease. More factors than fat mass per se determine the metabolic complications of obesity, including alterations in fat cell size, body fat distribution, adipose protein release, inflammation and lipolysis. The aim of this thesis was to further characterize the relationship between adipose tissue characteristics and metabolic parameters before and after weight loss, and to investigate if adipose phenotype can predict metabolic improvement after weight loss. Study I. At any given fat mass, adipose tissue may constitute of many small fat cells (hyperplasia) or few but large fat cells (hypertrophy). This latter morphology is associated with worse metabolic profile. Study I examined if adipose morphology, i.e. hyperplasia or hypertrophy, could predict improved insulin sensitivity after weight loss. Abdominal subcutaneous adipose biopsies were performed before weight loss by diet or RYGB. Body fat mass was measured by dual-energy x-ray absorptiometry (DXA) or bioimpedance and insulin sensitivity assessed by homeostasis model assessment of insulin resistance (HOMA-IR). Results showed a higher improvement in HOMA-IR in patients with hypertrophy. Study II. The degree of improvement in metabolic profile and adipose tissue phenotype after weight loss is in relation to weight stable controls is not fully understood. In this study, women that had undergone RYGB were compared with a weight stable matched control group. Subjects that had undergone RYGB had lower HOMA-IR, better lipid profile and higher adiponectin levels and their adipose tissue was characterized by smaller fat cells, less visceral fat and lower secretion of tumor necrosis factor α (TNF-α) than controls. Study III. Herein, the CC chemokine ligand 18 (CCL18) was examined in adipose tissue. CCL18 was found to be released from adipose tissue in a time dependent ...
    • File Description:
      application/pdf
    • Relation:
      I. Eriksson Hogling D, Andersson DP, Bäckdahl J, Hoffstedt J, Rössner S, Thorell A, Arner E, Arner P, Rydén M. Adipose tissue morphology predicts improved insulin sensitivity following moderate or pronounced weight loss. Int J Obes. 2015 Jun;39(6):893-8. ::doi::10.1038/ijo.2015.18 ::pmid::25666530 ::isi::000356039500004; II. Hoffstedt J, Andersson DP, Eriksson Hogling D, Theorell J, Näslund E, Thorell A, Ehrlund A, Rydén M, Arner P. Long-term Protective Changes in Adipose Tissue After Gastric Bypass. Diabetes Care. 2017 Jan;40(1):77-84. ::doi::10.2337/dc16-1072 ::pmid::27852664 ::isi::000390846100014; III. Eriksson Hogling D, Petrus P, Gao H, Bäckdahl J, Dahlman I, Laurencikiene J, Acosta J, Ehrlund A, Näslund E, Kulyte A, Mejhert N, Andersson DP, Arner P, Rydén M. Adipose and circulating CCL18 levels associate with metabolic risk factors in women. J Clin Endocrinol Metab. 2016 Nov;101(11):4021-4029. ::doi::10.1210/jc.2016-2390 ::pmid::27459538 ::isi::000390948600017; VI. Eriksson Hogling D, Rydén M, Bäckdahl J, Thorell A, Arner P, Andersson DP. Body fat mass and distribution as predictors of metabolic outcome and weight loss after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2018 Jul;14(7):936-942. ::doi::10.1016/j.soard.2018.03.012 ::pmid::29705562 ::isi::000442976300008; http://hdl.handle.net/10616/46603
    • الدخول الالكتروني :
      http://hdl.handle.net/10616/46603
    • Rights:
      info:eu-repo/semantics/openAccess
    • الرقم المعرف:
      edsbas.4F5BF2AE